Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer

PLoS Biology

Volumn 6, Issue 5, 2008, Pages 1098-1103

  Meyer, Kerstin B ^a   Maia, Ana Teresa ^a,b   O'Reilly, Martin ^a   Teschendorff, Andrew E ^a,b   Chin, Suet Feung ^a,b   Caldas, Carlos ^a,b   Ponder, Bruce A J ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; FIBROBLAST GROWTH FACTOR RECEPTOR 2; OCTAMER TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR RUNX2;

ALLELE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; GENE EXPRESSION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; INTRON; PROTEIN DNA INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 45149099137     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0060108     Document Type: Article

References (25)

1. Dickson C, Spencer-Dene B, Dillon C, Fantl V (2000) Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Res 2: 191-6.
2. Grose R, Dickson C (2005) Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 16: 179-86.
3. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, et al. (2007) MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 39: 759-69.
4. Luqmani YA, Graham M, Coombes RC (1992) Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 66: 273-80.
5. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
6. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9: 166-80.
7. Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, et al. (2004) Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene 23: 6047-55.
8. Tamaru N, Hishikawa Y, Ejima K, Nagasue N, Inoue S, et al. (2004) Estrogen receptor-associated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer. Lab Invest 84: 1460-71.
9. Tannheimer SL, Rehemtulla A, Ethier SP (2000) Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res 2: 311-20.
10. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-93.
11. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-4.
12. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, et al. (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26: 1507-16.
13. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype. Genome Biol 8: R214.
14. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. (2007) High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
15. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, et al. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Embo J 9: 1897-906.
16. Carstens RP, Eaton JV, Krigman HR, Walther PJ, Garcia-Blanco MA (1997) Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene 15: 3059-65.
17. Inman CK, Shore P (2003) The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem 278: 48684-9.
18. Inman CK, Li N, Shore P (2005) Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein. Mol Cell Biol 25: 3182-93.
19. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, et al. (2003) The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278: 319-26.
20. Guenou H, Kaabeche K, Mee SL, Marie PJ (2005) A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome. Hum Mol Genet 14: 1429-39.
21. Gutierrez S, Javed A, Tennant DK, van Rees M, Montecino M, et al. (2002) CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 277: 1316-23.
22. Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, et al. (2006) Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res 8: R56.
23. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-97.
24. Hishikawa Y, Tamaru N, Ejima K, Hayashi T, Koji T (2004) Expression of keratinocyte growth factor and its receptor in human breast cancer: its inhibitory role in the induction of apoptosis possibly through the overexpression of Bcl-2. Arch Histol Cytol 67: 455-64.
25. Meyer KB, Ireland J (1994) Activation of the immunoglobulin kappa 3′ enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core. Nucleic Acids Res 22: 1576-82.